Todd E. Meyerrose, Ph.D.
Affiliations: | 2007 | Washington University, Saint Louis, St. Louis, MO |
Area:
Cell BiologyGoogle:
"Todd Meyerrose"Parents
Sign in to add mentorDaniel C. Link | grad student | 2007 | Washington University | |
(Characterization of human mesenchymal stem cells and therapeutic application to a xenotransplant model of mucopolysaccharidosis type VII.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Meyerrose T, Olson S, Pontow S, et al. (2010) Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Advanced Drug Delivery Reviews. 62: 1167-74 |
Bauer G, Dao MA, Case SS, et al. (2008) In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1308-15 |
Meyerrose TE, Roberts M, Ohlemiller KK, et al. (2008) Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells (Dayton, Ohio). 26: 1713-22 |
Partlow KC, Chen J, Brant JA, et al. (2007) 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 1647-54 |
Meyerrose TE, De Ugarte DA, Hofling AA, et al. (2007) In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells (Dayton, Ohio). 25: 220-7 |
Wirthlin L, Meyerrose TE, Creer MH, et al. (2005) Involvement of Lipid Raft Domain Signaling in Ex Vivo Maintenance of Hematopoietic Progenitor Cells. Blood. 106: 4216-4216 |
Rosova I, Meyerrose TE, Nolta JA. (2005) Working Toward Better Tissue Repair Therapies: Exposure of MSC to Hypoxic Conditions In Vitro Increases Levels of the Hepatocyte Growth Factor Receptor c-met, Improves Motility, and Induces Phosphorylation of the Pro-Survival Protein AKT. Blood. 106: 2313-2313 |
Herrbrich PE, Meyerrose TE, Nolta JA. (2005) Exploring the Molecular Mechanisms for Enhancing MSC Homing and Lodgement within Sites of Liver Damage/Fibrosis. Blood. 106: 1690-1690 |
Meyerrose TE, Smith E, Nolta JA, et al. (2005) 1121. Osteogenic Growth Peptide Preferentially Enhances Trabecular Bone Mass Molecular Therapy. 11 |
Meyerrose TE, Herrbrich PE, Creer MH, et al. (2005) 1037. Adherent Human Umbilical Cord Blood Derived Mesenchymal Stem Cells Do Not Augment Viral Gene Transfer into Hematopoietic Stem/Progenitor Cells Molecular Therapy. 11 |